picornavirida
famili
consist
genera
speci
mainli
includ
enteroviru
hepatoviru
cardioviru
aphthoviru
rhinoviru
date
research
picornavirus
mainli
focus
enteroviru
ev
coxsackieviru
cv
polioviru
pv
encephalomyocard
viru
emcv
footandmouth
diseas
viru
fmdv
human
rhinoviru
hrv
hepat
viru
hav
picornaviru
infect
caus
enorm
damag
human
anim
caus
hand
foot
mouth
diseas
million
children
asiapacif
region
year
caus
seriou
clinic
symptom
asept
mening
acut
flaccid
paralysi
neurolog
respiratori
syndrom
picornavirus
nonenvelop
spheric
virus
icosahedralstructur
viral
capsid
picornavir
genom
consist
singlestrand
positivesens
rna
approxim
kilobas
length
highli
conserv
structur
includ
region
ncr
open
read
frame
polya
tail
contain
multipl
rna
secondari
structur
element
includ
intern
ribosom
entri
site
open
read
frame
viral
genom
consist
three
region
region
translat
process
form
structur
protein
compos
capsid
structur
picornaviru
region
separ
translat
nonstructur
protein
respect
major
relat
research
focus
structur
protein
picornavirus
wherea
import
nonstructur
protein
rel
overlook
viroporin
protein
found
varieti
virus
gener
compris
amino
acid
viroporin
contain
highli
hydrophob
domain
capabl
form
least
one
amphipath
structur
oligomer
form
transmembran
hydrophil
pore
protein
crucial
compon
picornavirus
exhibit
viroporin
viroporinlik
activ
play
key
role
picornaviru
life
cycl
induc
seri
cytotox
reaction
promot
picornavir
replic
releas
protein
highli
conserv
sequenc
exploit
viral
detect
vaccin
develop
rna
interfer
addit
protein
exhibit
viroporin
viroporinlik
activ
thu
target
drug
viroporin
could
potenti
target
protein
novel
strategi
treat
prevent
picornaviru
infect
howev
detail
mechan
action
protein
elucid
date
therefor
review
recent
research
data
role
protein
picornavir
life
cycl
discuss
possibl
applic
antivir
therapi
picornavir
protein
rel
short
molecul
contain
maximum
two
predict
put
transmembran
hydrophob
helic
along
n
ctermin
domain
connect
short
stretch
amino
acid
residu
sequenc
protein
basi
form
transmembran
pore
homomultimer
major
determin
protein
function
comput
approach
demonstr
ev
protein
tetram
protein
differ
orient
differ
activ
protein
belong
type
ii
famili
viroporin
divid
differ
type
accord
number
orient
membranespan
domain
figur
type
iia
viroporin
n
ctermini
stretch
organel
lumen
protein
wherea
n
ctermini
type
iib
viroporin
face
cytoplasm
matrix
pv
fmdv
addit
cterminu
hav
protein
viroporinlik
activ
picornavir
protein
target
membran
form
pore
mainli
transmembran
region
protein
molecul
first
insert
membran
individu
selfinteract
homooligomer
form
higherord
structur
import
poreform
activ
determin
specif
sequenc
structur
major
protein
local
organel
predomin
coloc
golgi
apparatu
endoplasm
reticulum
er
pv
figur
fmdv
protein
mainli
local
er
wherea
emcv
protein
local
either
golgi
complex
er
seggewiss
et
al
found
hav
protein
local
er
either
involv
amend
apparatu
intermedi
compart
sinc
protein
structur
determin
ultim
function
protein
belong
differ
viroporin
speci
show
similar
differ
function
much
insight
gain
research
viroporin
protein
differ
viroporin
common
featur
infect
anim
virus
damag
ion
balanc
host
cell
picornavir
protein
may
chang
membran
permeabl
target
cell
disturb
ion
balanc
especi
organel
er
golgi
apparatu
figur
chang
membran
permeabl
caus
protein
also
suggest
regul
content
specif
membran
phospholipid
involv
activ
enzym
cell
play
crucial
role
viral
replic
viral
biolog
process
howev
role
protein
homeostasi
remain
unclear
initi
studi
indic
host
cell
elev
level
owe
express
protein
mechan
clarifi
sinc
research
propos
decreas
concentr
store
organel
trigger
open
specif
calcium
ion
channel
plasma
membran
cell
caus
influx
extracellular
idea
support
find
express
pv
protein
result
obviou
decreas
concentr
er
golgi
complex
along
decreas
calcium
uptak
mitochondria
meanwhil
increas
level
cytoplasm
suggest
mainli
due
influx
extracellular
similarli
express
hrv
protein
shown
decreas
concentr
er
golgi
apparatu
wherea
emcv
protein
significantli
reduc
concentr
er
contrast
studi
show
express
hav
fmdv
protein
elev
cytoplasm
level
alter
level
store
organel
er
golgi
complex
taken
togeth
studi
suggest
differ
mechan
protein
affect
concentr
depend
viru
type
furthermor
unknown
whether
directli
pass
channel
form
protein
pham
et
al
demonstr
use
planar
lipid
bilay
liposom
patchclamp
electrophysiolog
techniqu
rotaviru
nonstructur
protein
viroporin
region
act
conduct
channel
although
current
direct
evid
protein
directli
induc
observ
chang
concentr
host
cell
upon
infect
abovereview
studi
suggest
associ
mechan
requir
investig
given
import
signal
numer
cellular
process
studi
picornavir
protein
function
includ
determin
concentr
may
provid
insight
detail
function
protein
particular
protein
may
chang
concentr
regul
autophagi
apoptosiswhich
distinct
cell
death
mechan
control
viru
effect
evad
host
immun
therebi
promot
viral
replic
releas
picornavirus
form
new
cytoplasm
vesicl
induc
membran
remodel
therebi
promot
prolifer
protein
capabl
bind
membran
induc
target
membran
remodel
form
uniqu
membran
structur
serv
viral
replic
site
site
known
viroplasm
gener
er
accumul
cellular
compon
requir
viral
replic
figur
viroplasm
also
main
membran
sourc
autophagi
protein
depend
transmembran
hydrophob
region
induc
autophagi
may
relat
alter
membran
permeabl
especi
regard
concentr
moreov
earli
stage
fmdv
cell
infect
viru
specif
recogn
bind
cell
surfac
receptor
protein
rapidli
upregul
autophagi
pathway
lead
punctat
aggreg
larg
number
autophagi
marker
protein
microtubuleassoci
protein
light
chain
addit
rotaviru
encod
viroporin
releas
erstor
cytoplasm
therebi
activ
kinas
signal
pathway
lead
autophagi
figur
induc
autophagi
calpaindepend
manner
caus
accumul
lipid
autophagosom
consid
abil
protein
alter
cellular
calcium
homeostasi
along
viroporinlik
activ
feasibl
protein
may
regul
autophagi
mainli
chang
concentr
protein
also
shown
regul
apoptosi
endogen
pathway
divid
er
stress
mitochondri
pathway
provid
anoth
potenti
mechan
bypass
host
immun
respons
facilit
infect
play
pivot
role
er
stressdepend
apoptosi
regul
flow
er
mitochondria
excess
mitochondri
uptak
exert
cytotox
effect
high
concentr
open
numer
mitochondri
transit
pore
increas
mitochondri
permeabl
destroy
mitochondri
outer
membran
consequ
cytochrom
c
proapoptot
factor
releas
lead
apoptosi
figur
protein
shown
inhibit
caspas
activ
cell
death
induc
actinomycin
cycloheximid
regul
intracellular
concentr
addit
protein
induc
er
stress
respons
accompani
increas
express
cleav
ccaatenhancerbind
protein
homolog
protein
chop
might
also
involv
chang
level
collect
result
suggest
protein
may
regul
apoptosi
alter
calcium
homeostasi
furthermor
protein
regul
apoptosi
mitochondri
pathway
madan
et
al
show
pv
protein
interact
mitochondria
alter
mitochondri
morpholog
addit
releas
cytochrom
c
pv
gene
express
cong
et
al
report
protein
local
mitochondria
induc
apoptosi
directli
activ
proapoptot
bcell
lymphoma
x
bax
protein
without
signific
uptak
mitochondria
therefor
activ
mitochondri
apoptot
pathway
subsequ
apoptosi
induc
protein
may
involv
signal
collect
picornavir
protein
induc
cell
death
varieti
way
play
import
role
mechan
host
immun
system
import
line
defens
pathogen
pathogen
affect
immun
system
varieti
way
protein
mainli
affect
host
immun
respons
inflammasom
activ
direct
antagon
host
immun
respons
recognit
pathogen
immun
system
mainli
mediat
pathogenassoci
molecular
pattern
receptor
known
pattern
recognit
receptor
includ
nucleotidebind
oligomer
domain
nod
like
receptor
nlr
retino
acidinduc
genei
rigi
like
helicas
pyrin
domaincontain
activ
inflammasom
occur
period
chang
ion
concentr
belong
nlr
famili
inflammasom
caus
interleukin
il
secret
via
activ
emcv
pv
hrv
protein
activ
inflammasom
use
distinct
mechan
hrv
emcv
protein
stimul
inflammasom
pathway
activ
catalyz
proteolysi
lead
secret
across
plasma
membran
induc
efflux
intracellular
storag
figur
wang
et
al
found
cell
induc
activ
associ
k
efflux
influenza
viru
protein
also
viroporin
capabl
transport
na
k
result
activ
inflammasom
sinc
protein
act
viroporin
disrupt
intracellular
ion
balanc
specul
induct
activ
cell
may
relat
protein
addit
activ
inflammasom
protein
also
antagon
host
immun
respons
vitro
vivo
studi
suggest
inhibit
protein
traffick
would
effect
allow
viral
evas
host
immun
respons
figur
moreov
inhibit
protein
transport
may
relat
chang
concentr
similar
protein
protein
pv
shown
significantli
inhibit
protein
transport
golgi
complex
wherea
hav
fmdv
emcv
protein
inhibit
protein
transport
fmdv
protein
block
protein
secret
wherea
transport
protein
er
golgi
complex
block
fmdv
protein
effect
reproduc
upon
coexpress
gene
collect
find
suggest
protein
may
particip
viral
evas
host
immun
respons
mainli
inhibit
protein
transport
protein
also
suggest
facilit
viral
evas
host
immun
respons
mean
thu
protein
antagon
rigimedi
antivir
respons
inhibit
express
rigi
fmdvspecif
reaction
rna
helicas
also
known
dexhbox
helicas
crucial
factor
involv
host
antivir
immun
respons
fmdv
leader
protein
lpro
protein
protein
abil
induc
decreas
protein
express
addit
pv
variant
shown
inhibit
antivir
interferon
ifn
system
wherea
hav
protein
inhibit
synthesi
affect
mitochondri
antivir
signal
protein
activ
therebi
antagon
host
immun
respons
collect
evid
indic
picornavir
protein
affect
host
immun
respons
therebi
promot
viral
amplif
releas
viral
particl
owe
highli
conserv
sequenc
use
gene
marker
could
effect
improv
accuraci
viru
detect
li
et
al
design
primer
taqman
probe
base
region
success
use
realtim
polymeras
chain
reaction
accur
detect
quantifi
fmdv
infect
replic
addit
wang
et
al
develop
lateralflow
detect
system
could
rapidli
easili
detect
fmdv
use
gene
addit
genebas
detect
viru
could
detect
use
antibodi
biswal
et
al
use
indirect
enzymelink
immunoassay
base
recombin
protein
detect
antibodi
specif
fmdv
method
appli
fmdv
also
picornavirus
includ
given
signific
threat
picornavirus
pose
human
anim
result
enorm
econom
damag
livestock
industri
develop
picornaviru
vaccin
great
signific
although
inactiv
viru
vaccin
offer
effect
prevent
associ
residu
risk
issu
includ
incomplet
viru
inactiv
escap
vaccin
product
process
therefor
genet
engin
vaccin
consid
suitabl
option
overcom
shortcom
inactiv
viral
vaccin
ev
protein
locat
outsid
viral
membran
thu
expos
greatest
amount
immun
stress
accordingli
show
extrem
serolog
variabl
thu
provid
reliabl
molecular
epidemiolog
inform
consequ
region
becom
focu
vaccin
research
picornaviru
infect
howev
dna
construct
contain
gene
show
low
level
antigen
therefor
still
need
develop
effect
adjuv
strategi
increas
antigen
one
possibl
regard
use
recombin
vaccin
incorpor
gene
enhanc
efficaci
vaccin
present
applic
gene
recombin
vaccin
mainli
concentr
fmdv
addit
fragment
vaccin
design
core
shown
effect
enhanc
vaccin
efficaci
reduc
dose
side
effect
effect
may
similar
lead
greater
efficaci
adenovir
vector
vaccin
fuse
fmdv
protein
serotyp
associ
induct
specif
protect
cell
respons
therefor
futur
design
picornavir
genet
engin
vaccin
would
benefit
addit
gene
increas
vaccin
efficaci
includ
addit
gene
genet
engin
ev
vaccin
gene
core
sinc
viroporin
play
import
role
life
stage
viru
attract
antivir
therapeut
target
great
breakthrough
regard
contrast
research
develop
drug
target
protein
rel
delay
sinc
protein
viroporin
viroporinlik
activ
screen
antipicornaviru
drug
among
exist
viroporintarget
drug
may
viabl
approach
four
main
type
inhibitor
viroporin
activ
includ
adamantan
amilorid
alkyl
iminosugar
spiran
amin
adamantan
amantadin
rimantadin
inhibit
channel
influenza
viru
destroy
transmembran
network
hydrogenbond
water
molecul
therebi
inhibit
viral
amplif
cell
infect
fmdv
viru
titer
gradual
decreas
increas
amantadin
concentr
may
due
abrog
poreform
activ
protein
ultim
inhibit
fmdv
replic
howev
clinic
trial
show
amantadin
select
specif
resist
mutat
hepat
c
viru
hcv
also
caus
rapid
emerg
amantadineresist
variant
influenza
viru
monotherapi
influenza
amilorid
composit
two
drug
n
nhexamethylen
amilorid
novel
inhibitor
target
hcv
vpu
togeth
block
viroporin
ion
channel
activ
prevent
ion
channel
format
result
potent
antivir
effect
alkyl
iminosugar
inhibit
format
ion
channel
target
hcv
viroporin
final
spiran
amin
also
inhibit
influenza
viru
protein
antivir
mechan
similar
amantadin
also
drug
act
viroporin
inhibitor
includ
hexahydropyrimidin
cd
n
phenylsulfonyl
emodin
among
other
mechan
action
viroporin
inhibitor
base
inhibit
viroporin
channel
activ
therefor
drug
may
potenti
appli
treatment
picornaviru
infect
target
gene
howev
applic
requir
detail
investig
drug
screen
nevertheless
protein
potenti
widen
rang
antivir
treatment
strategi
furthermor
specif
degrad
complementari
mrna
trigger
small
interf
rna
sirna
fold
short
hairpin
rna
shrna
explor
rna
interfer
strategi
rel
novel
technolog
alreadi
appli
treat
mani
import
pathogen
includ
hepat
b
viru
herp
simplex
viru
current
shrna
target
highli
conserv
gene
sequenc
wide
use
picornaviru
research
includ
fmdv
emcv
signific
experiment
viral
suppress
achiev
basic
rna
interfer
gene
affect
stabil
integr
whole
viral
genom
high
nucleotid
sequenc
conserv
make
gene
attract
target
rna
interfer
may
potenti
effect
multipl
picornaviru
type
open
door
addit
sirna
drug
date
studi
specif
focus
inhibitor
protein
xie
et
al
found
acid
did
block
chloridedepend
current
mediat
protein
suppress
viral
amplif
howev
research
need
uncov
underli
mechan
despit
mani
challeng
drug
develop
new
technolog
fouriertransform
infrar
spectroscopi
design
molecular
dynam
analog
well
cryoelectron
microscopi
spectroscopi
expect
greatli
contribut
develop
antivir
drug
recent
studi
gradual
clarifi
function
potenti
protein
along
increasingli
recogn
import
viral
life
cycl
howev
still
challeng
overcom
investig
picornavir
protein
particular
strong
hydrophob
make
difficult
achiev
solubl
express
ao
et
al
conjug
small
ubiquitinlik
modifi
sumo
protein
nterminu
fmdv
protein
success
achiev
solubl
express
therefor
method
test
picornavir
protein
moreov
detail
molecular
mechan
action
protein
requir
studi
along
identif
interact
protein
host
protein
better
understand
role
protein
pathogenesi
picornavirus
murin
cell
protein
suggest
react
host
protein
promot
rhinoviru
prolifer
use
yeast
twohybrid
system
fmdv
protein
found
interact
host
elong
factor
misloc
demonstr
delet
affect
synthesi
membran
protein
although
yeast
twohybrid
system
common
laboratori
proteinscreen
techniqu
low
success
rate
timeconsum
altern
affin
spectrometri
use
overcom
shortcom
alreadi
wide
use
studi
dengu
zika
ebola
virus
present
develop
antivir
drug
viroporin
focus
three
aspect
includ
viroporin
membran
fusion
inhibitor
ion
channel
inhibitor
target
viroporin
antibodi
respect
biolog
function
protein
antivir
drug
target
protein
could
design
base
follow
three
approach
broadspectrum
screen
antipicornaviru
drug
among
exist
viroporin
inhibitor
screen
protein
membran
fusion
inhibitor
screen
protein
pore
activ
inhibitor
discuss
herein
import
basi
function
protein
polymer
pore
therebi
chang
permeabl
membran
therefor
design
drug
target
protein
base
inhibit
polymer
protein
pore
therebi
reduc
effect
cellular
ion
homeostasi
howev
design
first
requir
detail
determin
refin
atom
structur
protein
along
expans
screen
techniqu
applic
meticul
medicin
chemistri
furthermor
develop
better
antivir
drug
necessari
elucid
exact
role
protein
channel
viral
life
cycl
thu
main
point
focu
research
structur
function
protein
toward
ultim
drug
develop
mechan
increas
membran
permeabl
disturb
ion
balanc
regul
autophagi
apoptosi
inhibit
host
immun
respons
promot
viral
replic
releas
taken
togeth
research
aim
elucid
role
protein
progress
along
adopt
new
technolog
expect
strategi
come
light
antivir
drug
develop
diseas
control
